Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of vortioxetine 10 mg tablets in healthy Thai volunteers
TCTR20220316001Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vortioxetine (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started Jul 2022; status: completed.
02
Drugs
vortioxetine
Beyond the preview
Go deeper on TCTR20220316001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220316001.